Literature DB >> 31863562

A severe adverse reaction to omalizumab therapy in chronic spontaneous urticaria.

Laura Dies1, Alvise Sernicola1, Francesca Magri1, Camilla Chello1, Giovanni Paolino1, Giorgia Carnicelli1, Valentina Faina1, Francesca Nencini2, Teresa Grieco1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31863562     DOI: 10.1111/dth.13204

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


× No keyword cloud information.
  2 in total

1.  Local reactions to the second dose of the BNT162 COVID-19 vaccine.

Authors:  Antonella Tammaro; Ganiyat Adenike Ralitsa Adebanjo; Francesca Romana Parisella; Gabriella De Marco; Jordi Rello
Journal:  Dermatol Ther       Date:  2021-06-01       Impact factor: 3.858

2.  Effects of Vaccination against COVID-19 in Chronic Spontaneous and Inducible Urticaria (CSU/CIU) Patients: A Monocentric Study.

Authors:  Teresa Grieco; Luca Ambrosio; Federica Trovato; Martina Vitiello; Ilaria Demofonte; Marta Fanto; Giovanni Paolino; Giovanni Pellacani
Journal:  J Clin Med       Date:  2022-03-25       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.